Table 5.

One-way sensitivity analysis on the ICERs (as expressed in dollars per patient maintained in target range)

Test	Selected variables	Cost per patient maintained in target range
INR	Base ICER	Dominated*
	GP consultations - Upper 95% CI	Dominated*
	GP consultations - Lower 95% CI	Dominated*
	Hospital admissions - Upper 95% CI	Dominated*
	Hospital admissions - Lower 95% CI	SW Quadrant**
HbA1c	Base ICER	$40
	GP consultations - Upper 95% CI	$1,049
	GP consultations - Lower 95% CI	Dominant***
	Hospital admissions - Upper 95% CI	$8,579
	Hospital admissions - Lower 95% CI	Dominant***
ACR	Base ICER	Dominant***
	GP consultations - Upper 95% CI	Dominant***
	GP consultations - Lower 95% CI	Dominant***
	Hospital admissions - Upper 95% CI	$17,647
	Hospital admissions - Lower 95% CI	Dominant***
Lipids	Base ICER	$10,082
	GP consultations - Upper 95% CI	$11,691
	GP consultations - Lower 95% CI	$8,618
	Hospital admissions - Upper 95% CI	$26,120
	Hospital admissions - Lower 95% CI	Dominant***

* Dominated: PoCT was more costly and less effective than laboratory testing

** SW Quadrant: PoCT was less costly and less effective than laboratory testing

***Dominant: PoCT was less costly and more effective than laboratory testing

Note: this analysis was undertaken on all the other variables (consumables, tests, emergency department visits, specialist consultations and pharmaceuticals) but did not have an influence on the ICERs ie change the quadrant.